← Back to Search

Virtual Reality for Postoperative Pain After Breast Reconstruction (VR4BR Trial)

N/A
Waitlist Available
Led By Alice Chung, MD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women who plan to undergo mastectomy and implant-based reconstruction
Age ≥ 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from operation to discharge, approximately 2 days
Awards & highlights

VR4BR Trial Summary

This trial will test if VR can help manage pain for women undergoing mastectomy and reconstruction.

Who is the study for?
This trial is for women over 18 who are planning to have a mastectomy and breast reconstruction. They must be able to understand English and follow the study's requirements. It's not for those with certain psychiatric disorders, epilepsy, dementia, sensitivity to flashing lights, motion sickness, frequent nausea or dizziness due to other conditions, or recent opioid use.Check my eligibility
What is being tested?
The study is testing how virtual reality (VR) can help manage pain after breast surgery without using opioids. Participants will use VR headsets that provide specialized programs designed to reduce pain during their recovery process.See study design
What are the potential side effects?
Since this trial involves non-drug therapy with VR, side effects may include discomfort from wearing the headset, eye strain or headache from prolonged screen time. Some might experience disorientation or mild nausea if prone to motion sickness.

VR4BR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Women who plan to have breast removal surgery and use implants for breast reconstruction.

VR4BR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from operation to discharge, approximately 2 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and from operation to discharge, approximately 2 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Morphine Milligram Equivalents
Secondary outcome measures
Mean difference in length of stay
Mean difference in pain

VR4BR Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual RealityExperimental Treatment1 Intervention
Every participant is provided with a VR headset
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1630

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
499 Previous Clinical Trials
164,809 Total Patients Enrolled
1 Trials studying Postoperative Pain
127 Patients Enrolled for Postoperative Pain
Alice Chung, MDPrincipal InvestigatorCedars-Sinai
2 Previous Clinical Trials
245 Total Patients Enrolled

Media Library

Virtual Reality Clinical Trial Eligibility Overview. Trial Name: NCT03801616 — N/A
Postoperative Pain Research Study Groups: Virtual Reality
Postoperative Pain Clinical Trial 2023: Virtual Reality Highlights & Side Effects. Trial Name: NCT03801616 — N/A
Virtual Reality 2023 Treatment Timeline for Medical Study. Trial Name: NCT03801616 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any open slots for participants in this investigation?

"As indicated on clinicaltrials.gov, this medical trial is no longer seeking participants at the moment. The study was first posted in January 2019 and underwent its last update in May 2022. However, there are currently 524 other trials that require patients for their research."

Answered by AI
~12 spots leftby Dec 2025